<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao Y</submitter><funding>National Institute on Alcohol Abuse and Alcoholism</funding><funding>NIDA NIH HHS</funding><funding>NIAAA NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>203-215</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7990506</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(3)</volume><pubmed_abstract>G protein-gated inwardly rectifying potassium (GIRK) channels are essential regulators of cell excitability in the brain. While they are implicated in a variety of neurological diseases in both human and animal model studies, their therapeutic potential has been largely untapped. Here, we review recent advances in the development of small molecule compounds that specifically modulate GIRK channels and compare them with first-generation compounds that exhibit off-target activity. We describe the method of discovery of these small molecule modulators, their chemical features, and their effects in vivo. These studies provide a promising outlook on the future development of subunit-specific GIRK modulators to regulate neuronal excitability in a brain region-specific manner.</pubmed_abstract><journal>Trends in pharmacological sciences</journal><pubmed_title>Advances in Targeting GIRK Channels in Disease.</pubmed_title><pmcid>PMC7990506</pmcid><funding_grant_id>R01 AA018734</funding_grant_id><funding_grant_id>R01 NS037682</funding_grant_id><funding_grant_id>R01 DA037170</funding_grant_id><funding_grant_id>R21 DA025236</funding_grant_id><funding_grant_id>R21 DA048623</funding_grant_id><funding_grant_id>R01 DA019022</funding_grant_id><pubmed_authors>Slesinger PA</pubmed_authors><pubmed_authors>Gameiro-Ros I</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Glaaser IW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Advances in Targeting GIRK Channels in Disease.</name><description>G protein-gated inwardly rectifying potassium (GIRK) channels are essential regulators of cell excitability in the brain. While they are implicated in a variety of neurological diseases in both human and animal model studies, their therapeutic potential has been largely untapped. Here, we review recent advances in the development of small molecule compounds that specifically modulate GIRK channels and compare them with first-generation compounds that exhibit off-target activity. We describe the method of discovery of these small molecule modulators, their chemical features, and their effects in vivo. These studies provide a promising outlook on the future development of subunit-specific GIRK modulators to regulate neuronal excitability in a brain region-specific manner.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2024-11-12T10:45:31.543Z</modification><creation>2024-11-12T10:45:31.543Z</creation></dates><accession>S-EPMC7990506</accession><cross_references><pubmed>33468322</pubmed><doi>10.1016/j.tips.2020.12.002</doi></cross_references></HashMap>